Comparison of oral and patch forms of hormonal contraception on plasma lipoproteins, glycemia, clotting factors, indices of inflammation and vascular reactivity

Trial Profile

Comparison of oral and patch forms of hormonal contraception on plasma lipoproteins, glycemia, clotting factors, indices of inflammation and vascular reactivity

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 11 Feb 2011

At a glance

  • Drugs Estradiol/norgestimate; Ethinylestradiol/norelgestromin
  • Indications Pregnancy
  • Focus Pharmacodynamics
  • Most Recent Events

    • 11 Feb 2011 Last checked against ClinicalTrials.gov record.
    • 11 Feb 2011 Planned End Date changed from 1 Jan 2009 to 1 Dec 2011 as reported by ClinicalTrials.gov.
    • 20 Aug 2008 Planned end date changed from 1 Dec 2008 to 1 Jan 2009 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top